ID

20779

Description

Yt90 Zevalin and Combination Chemotherapy (Z-CHOP)in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00386321

Link

https://clinicaltrials.gov/show/NCT00386321

Keywords

Versions (1)
  1. 3/16/17 3/16/17 -
Uploaded on

March 16, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diffuse Large B-cell Lymphoma NCT00386321

English

Eligibility Diffuse Large B-cell Lymphoma NCT00386321

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed cd20 positive diffuse large b-cell lymphoma with bulky stage ii or stage iii or stage iv
Description

Diffuse Large B-Cell Lymphoma CD20 positive Bulky Ann Arbor lymphoma staging system

Data type

boolean

Alias
UMLS CUI [1,1]
C0079744
UMLS CUI [1,2]
C3888518
UMLS CUI [1,3]
C1511341
UMLS CUI [1,4]
C0432516
bidimensionally measurable disease
Description

Measurable Disease 2-Dimensional

Data type

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1705052
performance status zubrod 0-2
Description

Zubrod Performance Status

Data type

boolean

Alias
UMLS CUI [1]
C3714786
less than 20,000/mcl circulating lymphoid cells on wbc differential count
Description

Differential white blood cell count Lymphoid Cells

Data type

boolean

Alias
UMLS CUI [1,1]
C0162401
UMLS CUI [1,2]
C0086574
no clinical evidence of cns involvement, no prior diagnosis of indolent lymphoma, no histologic transformation
Description

Central Nervous System Involvement Evidence | indolent lymphoma | Transformation Histologic

Data type

boolean

Alias
UMLS CUI [1,1]
C4050309
UMLS CUI [1,2]
C3887511
UMLS CUI [2]
C1334170
UMLS CUI [3,1]
C0040682
UMLS CUI [3,2]
C0205462
ejection fraction more than or equal to 45% by muga or no significant abnormality by echocardiogram
Description

Ejection fraction Multiple gated acquisition scanning | ECG normal

Data type

boolean

Alias
UMLS CUI [1,1]
C0489482
UMLS CUI [1,2]
C0521317
UMLS CUI [2]
C0522054
fertile patients with effective contraception method
Description

Fertility Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
no other malignancy within past 5 years except adequately treated basal cell or squamous cell skin cancer, stage i or ii cancer in complete remission, or carcinoma in situ of cervix
Description

Malignant Neoplasm | Basal cell carcinoma Treated | Squamous cell carcinoma of skin Treated | In complete remission TNM clinical staging | Carcinoma in situ of uterine cervix

Data type

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0007117
UMLS CUI [2,2]
C1522326
UMLS CUI [3,1]
C0553723
UMLS CUI [3,2]
C1522326
UMLS CUI [4,1]
C0677874
UMLS CUI [4,2]
C3258246
UMLS CUI [5]
C0851140
no hiv positive, no prior solid organ transplantation
Description

HIV Seropositivity | Solid organ transplant

Data type

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C0730400
no prior antibody therapy, chemotherapy, radiotherapy for lymphoma
Description

antibody therapy Lymphoma | Chemotherapy Lymphoma | Therapeutic radiology procedure Lymphoma

Data type

boolean

Alias
UMLS CUI [1,1]
C0281176
UMLS CUI [1,2]
C0024299
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C0024299
UMLS CUI [3,1]
C1522449
UMLS CUI [3,2]
C0024299
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
serum creatinine ot bilirubin more than 2.5 x uln unless due to lymphoma
Description

Serum creatinine raised | Elevated total bilirubin | Lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0700225
UMLS CUI [2]
C0741494
UMLS CUI [3]
C0024299
active uncontrolled infection
Description

Communicable Disease Uncontrolled

Data type

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205318
concurrent severe and/or uncontrolled medical disease which could compromise participation in the study
Description

Comorbidity Severe compromises Study Subject Participation Status | Comorbidity Uncontrolled compromises Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C2945640
UMLS CUI [1,4]
C2348568
UMLS CUI [2,1]
C0009488
UMLS CUI [2,2]
C0205318
UMLS CUI [2,3]
C2945640
UMLS CUI [2,4]
C2348568
patients with more than 25% infiltrated bone marrow
Description

Bone marrow infiltration Percentage

Data type

boolean

Alias
UMLS CUI [1,1]
C3854434
UMLS CUI [1,2]
C0439165
patients with platelet counts less than 100,000/mcl or neutrophil counts less than 1,500/mcl
Description

Platelet Count measurement | Absolute neutrophil count

Data type

boolean

Alias
UMLS CUI [1]
C0032181
UMLS CUI [2]
C0948762
Back to the top of the page

Similar models

Eligibility Diffuse Large B-cell Lymphoma NCT00386321

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Diffuse Large B-Cell Lymphoma CD20 positive Bulky Ann Arbor lymphoma staging system
Item
histologically confirmed cd20 positive diffuse large b-cell lymphoma with bulky stage ii or stage iii or stage iv
boolean
C0079744 (UMLS CUI [1,1])
C3888518 (UMLS CUI [1,2])
C1511341 (UMLS CUI [1,3])
C0432516 (UMLS CUI [1,4])
Measurable Disease 2-Dimensional
Item
bidimensionally measurable disease
boolean
C1513041 (UMLS CUI [1,1])
C1705052 (UMLS CUI [1,2])
Zubrod Performance Status
Item
performance status zubrod 0-2
boolean
C3714786 (UMLS CUI [1])
Differential white blood cell count Lymphoid Cells
Item
less than 20,000/mcl circulating lymphoid cells on wbc differential count
boolean
C0162401 (UMLS CUI [1,1])
C0086574 (UMLS CUI [1,2])
Central Nervous System Involvement Evidence | indolent lymphoma | Transformation Histologic
Item
no clinical evidence of cns involvement, no prior diagnosis of indolent lymphoma, no histologic transformation
boolean
C4050309 (UMLS CUI [1,1])
C3887511 (UMLS CUI [1,2])
C1334170 (UMLS CUI [2])
C0040682 (UMLS CUI [3,1])
C0205462 (UMLS CUI [3,2])
Ejection fraction Multiple gated acquisition scanning | ECG normal
Item
ejection fraction more than or equal to 45% by muga or no significant abnormality by echocardiogram
boolean
C0489482 (UMLS CUI [1,1])
C0521317 (UMLS CUI [1,2])
C0522054 (UMLS CUI [2])
Fertility Contraceptive methods
Item
fertile patients with effective contraception method
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Malignant Neoplasm | Basal cell carcinoma Treated | Squamous cell carcinoma of skin Treated | In complete remission TNM clinical staging | Carcinoma in situ of uterine cervix
Item
no other malignancy within past 5 years except adequately treated basal cell or squamous cell skin cancer, stage i or ii cancer in complete remission, or carcinoma in situ of cervix
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C0553723 (UMLS CUI [3,1])
C1522326 (UMLS CUI [3,2])
C0677874 (UMLS CUI [4,1])
C3258246 (UMLS CUI [4,2])
C0851140 (UMLS CUI [5])
HIV Seropositivity | Solid organ transplant
Item
no hiv positive, no prior solid organ transplantation
boolean
C0019699 (UMLS CUI [1])
C0730400 (UMLS CUI [2])
antibody therapy Lymphoma | Chemotherapy Lymphoma | Therapeutic radiology procedure Lymphoma
Item
no prior antibody therapy, chemotherapy, radiotherapy for lymphoma
boolean
C0281176 (UMLS CUI [1,1])
C0024299 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0024299 (UMLS CUI [2,2])
C1522449 (UMLS CUI [3,1])
C0024299 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Serum creatinine raised | Elevated total bilirubin | Lymphoma
Item
serum creatinine ot bilirubin more than 2.5 x uln unless due to lymphoma
boolean
C0700225 (UMLS CUI [1])
C0741494 (UMLS CUI [2])
C0024299 (UMLS CUI [3])
Communicable Disease Uncontrolled
Item
active uncontrolled infection
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Comorbidity Severe compromises Study Subject Participation Status | Comorbidity Uncontrolled compromises Study Subject Participation Status
Item
concurrent severe and/or uncontrolled medical disease which could compromise participation in the study
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C2945640 (UMLS CUI [1,3])
C2348568 (UMLS CUI [1,4])
C0009488 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C2945640 (UMLS CUI [2,3])
C2348568 (UMLS CUI [2,4])
Bone marrow infiltration Percentage
Item
patients with more than 25% infiltrated bone marrow
boolean
C3854434 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
Platelet Count measurement | Absolute neutrophil count
Item
patients with platelet counts less than 100,000/mcl or neutrophil counts less than 1,500/mcl
boolean
C0032181 (UMLS CUI [1])
C0948762 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial